Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26960,100,1.34 [0.95-1.87],0.0924816166338039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27517,143,1.32 [1.00-1.76],0.0504387964887349
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27266,972,1.20 [1.08-1.34],0.0011648721300139
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Candidiasis,27547,297,1.12 [0.91-1.37],0.2860499236620432
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26772,2704,1.18 [1.10-1.26],2.4742766157071507e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27018,2040,1.13 [1.05-1.22],0.0017500052605349
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27342,983,1.23 [1.11-1.38],0.0001728068616531
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27465,45,0.95 [0.55-1.64],0.8633691659755784
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26305,625,1.20 [1.04-1.38],0.0102153139726325
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25440,601,1.34 [1.17-1.54],2.921549827542508e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25677,166,1.12 [0.85-1.47],0.4366345644863979
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20536,1185,1.22 [1.11-1.35],7.969105169600207e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25446,276,1.51 [1.24-1.84],4.189205963820105e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27501,1142,1.25 [1.13-1.39],1.3228339696611083e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Mycoses,27606,356,1.09 [0.90-1.31],0.394059577191122
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26882,588,1.29 [1.12-1.48],0.000413565288189
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27549,689,1.19 [1.04-1.36],0.0098430836317375
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26503,144,1.32 [1.00-1.75],0.0541717002157985
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27646,33,1.73 [1.01-2.96],0.0453174340493761
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27465,605,1.18 [1.02-1.36],0.0237545466920158
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27490,70,1.25 [0.83-1.88],0.2842150083241747
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27553,168,1.51 [1.18-1.94],0.0012912382539921
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27538,153,1.52 [1.17-1.98],0.0016845007575416
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26622,328,1.33 [1.11-1.61],0.0023868574656157
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26527,233,1.10 [0.87-1.40],0.4023550115263721
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26437,78,1.66 [1.16-2.38],0.0055143906695894
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27617,54,0.82 [0.49-1.38],0.4612565351473429
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27584,127,1.18 [0.87-1.61],0.2816450562754928
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral warts,27501,44,0.67 [0.37-1.19],0.171351866155987
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27506,49,1.65 [1.05-2.59],0.0286426832729647
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,27359,315,1.07 [0.88-1.31],0.507540471688807
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27555,75,1.20 [0.80-1.78],0.3817499990291548
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27536,79,1.33 [0.91-1.94],0.1415959623479888
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12319,44,1.01 [0.59-1.72],0.9808918867162192
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27453,1174,0.98 [0.88-1.09],0.7340800585684485
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of meninges,27634,46,1.18 [0.70-1.97],0.5396621707601932
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27611,49,1.03 [0.62-1.72],0.908188200197407
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27624,87,1.27 [0.88-1.83],0.2036935002087027
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of ovary,15267,98,1.03 [0.71-1.48],0.8815129887181516
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27639,270,0.83 [0.66-1.04],0.1115091372986478
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Caecum,27635,205,0.96 [0.74-1.23],0.7282349014577664
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27578,57,1.06 [0.66-1.71],0.7968644216470184
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Descending colon,27638,173,0.77 [0.58-1.03],0.0752112991148754
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Rectum,27602,288,1.06 [0.86-1.30],0.6110523238740836
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27572,539,0.92 [0.79-1.08],0.2996505441903442
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27639,309,0.91 [0.74-1.13],0.4005460246244942
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Carcinoma in situ of breast,13139,87,0.54 [0.35-0.84],0.0055131939848539
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13187,100,0.57 [0.38-0.85],0.0060311780984524
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",23902,31,3.95 [2.76-5.66],7.7783722748743e-14
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",23908,37,1.11 [0.62-1.98],0.7355277267851462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27606,109,0.81 [0.56-1.16],0.2453908253686577
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma, any site",27606,107,0.83 [0.57-1.19],0.2983895266232498
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Leiomyoma of uterus,14633,414,0.91 [0.75-1.09],0.2937620937542017
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lung cancer and mesothelioma,20569,176,1.16 [0.88-1.52],0.2903135341391101
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lymphoid leukaemia,23900,29,4.12 [2.94-5.78],2.289223327765885e-16
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24018,147,1.02 [0.76-1.37],0.9022660162927902
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",23956,85,0.94 [0.63-1.40],0.7570894247625504
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13241,84,0.97 [0.65-1.44],0.8663673773408638
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",23922,51,1.18 [0.72-1.94],0.5101069347778182
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",23934,63,1.16 [0.75-1.81],0.5023397126801161
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",23940,69,1.08 [0.70-1.67],0.7272094456326346
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13210,53,1.02 [0.62-1.68],0.9455492275281878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",23927,56,1.01 [0.62-1.65],0.9554373293537504
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11123,409,1.18 [0.99-1.40],0.0606874604140741
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",23957,86,0.90 [0.60-1.34],0.596688539089276
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",23925,54,1.50 [0.95-2.37],0.080165506109376
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,23935,64,1.01 [0.64-1.58],0.9812837506091332
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi,27407,212,1.04 [0.82-1.33],0.7369863638361104
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of trunk,27597,93,0.99 [0.68-1.44],0.9719644938738812
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanoma in situ,23885,50,0.93 [0.55-1.58],0.7970474427810369
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",23929,58,1.02 [0.64-1.64],0.9336343545804044
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",23987,116,1.42 [1.04-1.93],0.0278700817781623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",23993,122,1.13 [0.81-1.57],0.4629156103766515
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",23939,68,1.30 [0.86-1.97],0.2188794229199383
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Other benign neoplasms of skin,27463,135,1.14 [0.84-1.54],0.4060266785397289
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24512,641,1.07 [0.93-1.23],0.3387741040510996
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24542,671,1.07 [0.94-1.23],0.302207979201758
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27379,280,1.20 [0.97-1.48],0.0852773683111744
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26240,57,1.44 [0.93-2.25],0.1047425164250325
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27167,68,1.62 [1.10-2.39],0.0141093181776983
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26851,2216,1.14 [1.06-1.23],0.0006072985128316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26462,24,1.84 [0.98-3.45],0.0577984419022728
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27296,36,1.51 [0.88-2.59],0.1339263320111188
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27202,1019,1.20 [1.07-1.34],0.0011473481732644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27202,1019,1.20 [1.07-1.34],0.0011473481732644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26240,57,1.34 [0.85-2.11],0.2127449785274181
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27362,924,1.18 [1.06-1.33],0.0039417316190666
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27373,113,1.11 [0.79-1.55],0.5441573576063179
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27152,53,1.26 [0.79-2.01],0.334136975905153
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27142,43,1.66 [1.02-2.69],0.0405596822612679
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27450,190,1.13 [0.87-1.46],0.3545033377507658
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27568,69,1.26 [0.83-1.90],0.2722127038227611
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27418,158,1.03 [0.78-1.38],0.8202024191225855
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26513,75,1.35 [0.91-2.01],0.1309670816061396
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,23760,208,1.37 [1.09-1.74],0.0080359879722018
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25720,128,1.16 [0.86-1.58],0.3238438995202268
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25728,136,1.47 [1.12-1.94],0.0057213433898276
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,23590,38,1.79 [1.09-2.92],0.0208650950711802
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25670,70,1.35 [0.90-2.02],0.1472823504951041
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25337,150,1.17 [0.88-1.55],0.2831752845062651
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27500,165,1.11 [0.84-1.47],0.4501655653256404
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27380,45,1.04 [0.61-1.77],0.8878870886486167
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27371,36,0.84 [0.45-1.56],0.5743764451414545
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27237,1637,1.08 [0.99-1.18],0.0708353299867946
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24753,1587,1.09 [0.99-1.19],0.0717909835620036
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",23592,40,0.96 [0.54-1.71],0.8914768792744184
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",25968,58,0.69 [0.42-1.15],0.1581271760995879
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,23738,186,1.52 [1.19-1.93],0.000709560878945
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,23616,64,1.73 [1.18-2.55],0.0052183660950863
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25937,2385,1.27 [1.19-1.37],1.8414860620283088e-11
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,23670,118,1.27 [0.92-1.74],0.1466729910688928
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,23939,387,1.36 [1.14-1.61],0.0005023188718962
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27545,269,1.26 [1.03-1.56],0.0277743868614057
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27384,108,1.49 [1.09-2.04],0.01313513482389
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,23650,98,1.09 [0.76-1.57],0.6307842357160548
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",23592,40,1.30 [0.76-2.24],0.3403585086405513
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27217,1307,1.15 [1.04-1.27],0.0048405489815105
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,23678,126,1.19 [0.87-1.62],0.2828096723852928
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,23713,161,1.40 [1.08-1.82],0.0111139790780105
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",23939,387,1.26 [1.06-1.51],0.0091728914120432
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,23611,59,1.40 [0.90-2.18],0.1330534775062132
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27377,101,1.45 [1.05-2.02],0.0252503248534606
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,23850,298,1.31 [1.07-1.59],0.0083477625185231
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,23852,300,1.12 [0.91-1.38],0.2764189632114576
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25245,58,1.10 [0.69-1.75],0.6958285699303955
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26961,3409,1.23 [1.16-1.30],8.801508409725957e-12
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,25948,38,0.83 [0.45-1.53],0.5523182492302493
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,25969,59,1.17 [0.75-1.85],0.4888564515605631
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27464,1923,0.99 [0.91-1.08],0.8289756081770228
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27468,1920,0.99 [0.91-1.07],0.8157926281116484
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,25947,37,1.78 [1.07-2.95],0.0265520667406338
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27321,1238,1.07 [0.97-1.18],0.1990914146733216
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24441,889,1.25 [1.11-1.40],0.0001442612143373
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27636,136,1.39 [1.05-1.85],0.0224079699026207
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27370,35,1.00 [0.54-1.86],0.991823253474148
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26169,86,1.04 [0.70-1.53],0.8478949065067978
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26201,118,1.22 [0.89-1.68],0.2215155598255251
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",23683,131,1.55 [1.16-2.06],0.002968446705512
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25868,119,1.50 [1.11-2.03],0.0077464922501984
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1685,69,1.31 [0.88-1.97],0.185529728590971
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1794,193,1.15 [0.90-1.48],0.2516244623983084
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25789,40,1.12 [0.65-1.92],0.6839318890312678
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1653,37,2.03 [1.32-3.13],0.0013735689017016
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27226,1477,1.26 [1.15-1.38],3.312104151578546e-07
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27405,70,0.90 [0.58-1.40],0.6368105257588033
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25461,274,1.22 [0.99-1.51],0.0592701436098484
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23960,408,1.25 [1.06-1.49],0.0090325608747939
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27558,177,1.04 [0.80-1.36],0.7715839300552476
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26922,55,1.01 [0.62-1.65],0.9552312930233136
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,26371,785,1.10 [0.97-1.25],0.1458509866011316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26968,101,1.13 [0.80-1.60],0.4796048578997708
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26898,31,1.88 [1.09-3.23],0.023084329227111
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26971,104,1.54 [1.12-2.11],0.0074095029734484
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19733,930,1.01 [0.89-1.13],0.9139408879494014
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,AV-block,25188,180,0.99 [0.76-1.30],0.9622141218329148
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27615,257,0.89 [0.71-1.12],0.3316702745948999
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiac arrest,18921,118,1.37 [1.01-1.86],0.0446442292190363
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25145,137,1.03 [0.76-1.39],0.867313957118597
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25090,82,0.85 [0.57-1.29],0.4487370867215158
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27648,20,0.42 [0.16-1.06],0.0671552011542196
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Conduction disorders,25532,524,1.09 [0.94-1.27],0.2546979054951216
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26931,1355,1.27 [1.15-1.39],6.900067077470466e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25705,5998,1.12 [1.07-1.17],1.6511372886287954e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26488,186,1.05 [0.81-1.36],0.7078811456795462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Endocarditis,25049,41,1.14 [0.66-1.97],0.6434379911984174
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27530,505,1.13 [0.96-1.32],0.1316370086097227
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,26277,4884,1.13 [1.07-1.19],2.4102014922257675e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26293,4900,1.13 [1.07-1.19],1.985556035850356e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27481,56,1.09 [0.68-1.76],0.7165346801103463
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21481,88,1.19 [0.82-1.73],0.3594952343698773
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21455,62,1.74 [1.19-2.55],0.0042336302912975
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,27543,689,1.19 [1.04-1.36],0.0095465510945771
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27122,65,1.19 [0.77-1.84],0.4429710807197098
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27086,1500,1.23 [1.12-1.34],7.312411400134692e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27420,304,1.15 [0.94-1.41],0.1628623054179363
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25197,189,1.31 [1.02-1.67],0.0311410547706807
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27393,596,1.20 [1.04-1.38],0.0106811484947647
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26072,486,1.25 [1.07-1.47],0.0044722698065763
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27593,116,1.12 [0.81-1.55],0.5087158315617426
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27633,206,1.22 [0.96-1.55],0.1042257097911549
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Oesophageal varices,26343,41,1.32 [0.78-2.22],0.298094998448378
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other aneurysm,26916,49,0.77 [0.45-1.32],0.3385608115319004
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arrhythmias,25248,240,1.24 [0.99-1.54],0.0577870199313501
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26931,64,1.56 [1.04-2.33],0.0317549267842311
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27003,136,1.11 [0.81-1.50],0.5197476451198699
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25137,129,0.93 [0.68-1.29],0.6774544382399698
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other disorders of veins,26376,74,0.98 [0.65-1.50],0.9379423923170284
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26349,47,1.21 [0.73-2.00],0.4667656307998238
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26869,34,0.94 [0.51-1.74],0.844254651178661
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26390,88,0.93 [0.63-1.38],0.7269316130187422
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25586,578,1.15 [0.99-1.33],0.0643301919047509
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26899,45,1.44 [0.87-2.36],0.1527526680433552
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27205,338,1.27 [1.05-1.53],0.0122537601291253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27205,159,1.45 [1.11-1.89],0.0059101722361462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27069,234,1.00 [0.79-1.27],0.9912376006705276
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19052,249,0.93 [0.74-1.18],0.5593730615686194
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27045,204,1.47 [1.17-1.85],0.001066357510835
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26559,257,1.04 [0.83-1.30],0.719049066688395
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27383,337,1.13 [0.94-1.37],0.1970459604282321
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27607,331,1.20 [0.99-1.45],0.0612001058399881
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25182,174,1.00 [0.77-1.32],0.9720459398455702
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27201,155,1.41 [1.08-1.85],0.0127816652544146
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26953,118,1.26 [0.92-1.72],0.1542897924422068
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27413,356,1.15 [0.95-1.38],0.1550926963423101
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27387,391,1.10 [0.92-1.32],0.2909001823085321
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27098,54,0.79 [0.47-1.32],0.3646366657491865
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26919,53,0.90 [0.54-1.49],0.6811315659790538
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27257,141,1.17 [0.88-1.57],0.2808135989122624
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26976,179,1.17 [0.90-1.52],0.2372041442567929
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Varicose veins,26620,318,0.80 [0.65-0.99],0.0380168375418707
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26877,49,0.81 [0.47-1.38],0.4346831075097496
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27474,532,1.04 [0.89-1.21],0.6232184731236775
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27491,378,1.17 [0.98-1.40],0.0802903139412396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24644,1422,1.11 [1.01-1.22],0.0313613315795586
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,26895,3673,1.10 [1.04-1.17],0.0010331125542689
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27427,447,1.14 [0.96-1.34],0.1286063881861354
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24888,1666,1.10 [1.01-1.20],0.0306027578562103
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23317,95,1.17 [0.82-1.68],0.3829819308500001
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,27111,1524,1.15 [1.05-1.26],0.0020930640534873
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24989,1767,1.15 [1.06-1.25],0.000921325954253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Vascular dementia,27535,21,1.40 [0.68-2.86],0.3609996877431533
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Alzheimer disease,27648,63,0.90 [0.57-1.43],0.6545667283787322
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Bell's palsy,25996,73,0.91 [0.59-1.40],0.6686552540972639
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26389,466,1.18 [1.00-1.38],0.049466670824606
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral cysts,27296,206,1.12 [0.88-1.43],0.360699800670592
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27565,225,1.16 [0.92-1.47],0.208317216466152
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27510,23,0.55 [0.24-1.25],0.1555197787398472
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27634,52,1.40 [0.88-2.20],0.1524007876847154
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27148,58,0.81 [0.50-1.33],0.4056600015515575
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Epilepsy,26082,257,1.13 [0.90-1.40],0.2916645912910096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27160,1335,1.13 [1.02-1.24],0.0159141377599482
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27618,269,1.10 [0.88-1.36],0.4001022568800105
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27136,1645,1.02 [0.93-1.12],0.6354346956933888
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Generalized epilepsy,27275,50,1.53 [0.98-2.38],0.0632122367968446
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hemiplegia,27502,162,1.06 [0.80-1.41],0.6823167476690717
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hydrocephalus,27136,46,1.50 [0.94-2.42],0.0905761698903999
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27625,60,1.31 [0.85-2.03],0.2230516437650835
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26000,77,0.77 [0.50-1.19],0.2368769738483639
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26005,82,1.73 [1.23-2.44],0.0018212154114032
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Memory loss,27501,73,1.20 [0.80-1.79],0.3858988132935088
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Migraine,26252,427,1.18 [0.99-1.40],0.0574597376229309
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27555,380,1.17 [0.98-1.40],0.0904015490043492
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Motor neuron disease,20129,96,1.01 [0.70-1.45],0.9719053506289732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27454,144,1.09 [0.81-1.47],0.55237283447254
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27039,1116,1.21 [1.09-1.34],0.0003642446802145
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,26219,3055,1.11 [1.04-1.19],0.0009820133573836
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27560,73,1.13 [0.75-1.71],0.5556131925214578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26311,388,1.21 [1.01-1.44],0.0374166990843215
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27576,235,1.17 [0.93-1.47],0.1774921310064744
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23070,302,1.07 [0.87-1.31],0.5439852122243011
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27150,60,0.88 [0.55-1.42],0.6067571605882599
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27203,113,0.97 [0.69-1.36],0.8421829884222897
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27439,90,1.22 [0.85-1.76],0.2766303824428189
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26013,90,0.93 [0.63-1.37],0.7172294489251498
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other headache syndromes,25883,58,1.13 [0.70-1.81],0.6152685294823027
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other neurological diseases,27528,438,1.14 [0.96-1.35],0.1271495734121675
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other sleep disorders,26399,574,1.08 [0.93-1.25],0.3307644805334474
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Parkinson's disease,27635,157,1.06 [0.80-1.41],0.6701196104643876
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27154,64,1.31 [0.86-2.01],0.2080578226444618
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Restless leg syndrome,27647,45,1.22 [0.73-2.05],0.4431907819719403
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Sleep apnoea,27404,500,1.10 [0.94-1.28],0.2476656240075587
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27377,36,1.63 [0.98-2.72],0.0597039429626408
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27634,122,0.99 [0.72-1.38],0.96703428529452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25954,31,1.72 [0.97-3.03],0.0611638515326729
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27648,64,0.95 [0.60-1.50],0.8299728727295581
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27523,20,1.36 [0.65-2.86],0.4129269369293901
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27166,43,1.30 [0.78-2.18],0.3122306159337473
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27303,218,1.00 [0.78-1.28],0.9902256675096572
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27558,195,1.21 [0.94-1.55],0.1341633993500009
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26901,37,1.14 [0.64-2.03],0.6543405722622699
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26939,75,1.23 [0.83-1.83],0.3063896698272751
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27561,30,0.89 [0.45-1.76],0.7421612043710575
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27446,66,1.33 [0.88-2.02],0.1772590530686916
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1660,44,2.15 [1.46-3.19],0.0001180872826286
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1965,85,1.27 [0.88-1.82],0.1987482875598761
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27200,77,1.11 [0.75-1.66],0.6017746281954681
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27520,618,1.12 [0.97-1.29],0.1164385561512204
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27337,473,0.99 [0.84-1.17],0.919734133875972
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26999,135,0.92 [0.67-1.27],0.6271761188071832
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27556,471,1.05 [0.89-1.23],0.5816666474395072
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27635,50,0.97 [0.58-1.62],0.9119081838066684
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27484,399,1.08 [0.91-1.29],0.3848603812595651
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27604,224,1.37 [1.10-1.72],0.0052439787610888
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27585,127,0.92 [0.67-1.28],0.6304385782179089
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26882,18,1.07 [0.46-2.45],0.881305560315634
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26893,29,1.07 [0.56-2.07],0.8343067194620388
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26896,32,0.82 [0.42-1.59],0.5486717988953171
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27600,384,1.19 [1.00-1.42],0.053754746695973
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27316,100,0.83 [0.57-1.21],0.3311203996013354
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27109,24,1.34 [0.68-2.66],0.4010326702953328
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27454,74,1.55 [1.07-2.24],0.0216266027297329
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27530,150,1.31 [1.00-1.73],0.0538296796735477
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27244,159,1.20 [0.91-1.57],0.1981521812860907
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27534,76,0.84 [0.55-1.28],0.4107646054959364
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27469,253,1.36 [1.10-1.68],0.0047541959270393
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27238,115,1.50 [1.10-2.03],0.0093348465696783
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26929,1041,1.14 [1.02-1.27],0.0205148982713336
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27503,123,1.21 [0.89-1.66],0.2248110065892281
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27621,113,1.02 [0.73-1.43],0.923107537556661
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27123,259,1.08 [0.87-1.35],0.4827581268550528
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27416,36,1.70 [1.02-2.83],0.0405039795594194
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27620,35,1.07 [0.59-1.94],0.83263559580111
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26903,39,1.03 [0.58-1.83],0.9115351506478566
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26978,114,1.18 [0.85-1.64],0.3197388000577549
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26971,69,0.75 [0.47-1.19],0.2193908650152952
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27143,58,1.11 [0.70-1.77],0.6482470866307597
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26952,50,1.00 [0.60-1.67],0.9982918756600652
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27273,57,1.16 [0.73-1.85],0.5244959799747237
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27309,93,1.41 [1.00-1.98],0.0522049460211963
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26951,87,1.41 [0.99-2.01],0.059318126298175
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27024,122,1.44 [1.07-1.93],0.016400489910789
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26937,35,1.47 [0.85-2.56],0.1724451601896348
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26717,829,1.08 [0.96-1.23],0.2034323898858428
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26912,48,0.69 [0.40-1.20],0.1881995320460961
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27432,309,1.27 [1.05-1.55],0.0144292770258178
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27162,39,1.20 [0.69-2.07],0.519488387995072
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27252,129,1.10 [0.80-1.50],0.5526598402968768
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27453,61,0.80 [0.49-1.30],0.3705803759804795
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27605,97,1.23 [0.87-1.74],0.2471541007130784
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27527,133,1.04 [0.76-1.42],0.7905406549901244
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27444,52,1.31 [0.82-2.10],0.2595580098991514
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27444,52,1.20 [0.75-1.94],0.4441028500230818
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27557,526,1.12 [0.96-1.30],0.1575528658126879
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27357,326,1.24 [1.02-1.49],0.0285050726864047
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27126,95,0.97 [0.67-1.41],0.8696524858685355
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27113,82,1.17 [0.79-1.72],0.4382970360629941
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute pharyngitis,27359,80,1.01 [0.67-1.52],0.9583239169490714
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27514,235,0.89 [0.70-1.13],0.3300727736591717
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27342,63,0.97 [0.61-1.54],0.8943965568356597
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,All influenza,26350,75,1.31 [0.88-1.95],0.1825837283189961
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26348,73,1.35 [0.91-2.01],0.1406754409141807
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Allergic asthma (mode),20516,123,0.96 [0.69-1.33],0.8120555845181364
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Allergic rhinitis,27497,308,1.09 [0.89-1.33],0.4157591004445693
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21992,1738,1.08 [0.99-1.17],0.0801371271547388
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22102,1709,1.09 [1.00-1.19],0.0439223027596503
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27369,93,1.41 [1.00-2.00],0.0498977528441147
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26331,56,1.61 [1.05-2.47],0.0299604149807179
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bronchiectasis,24640,185,1.14 [0.88-1.47],0.3386204509137362
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",24497,42,1.00 [0.57-1.74],0.9955648890091456
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26793,2338,1.08 [1.00-1.16],0.0397430043295153
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26178,67,0.82 [0.52-1.30],0.397786878024743
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic sinusitis,26277,166,1.32 [1.01-1.71],0.0397968037708245
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27545,718,1.09 [0.95-1.24],0.2141530419849976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Deviated nasal septum,26241,130,1.17 [0.87-1.59],0.3043011105213968
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25747,4243,1.10 [1.05-1.17],0.0003135292968792
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26493,382,1.02 [0.85-1.23],0.8212588792534097
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Early onset COPD,27328,501,1.06 [0.90-1.24],0.4922135188541623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Emphysema,24642,187,1.40 [1.10-1.79],0.0072357414378015
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26404,112,1.27 [0.92-1.76],0.1405922596147241
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27465,1190,1.16 [1.05-1.28],0.0041736648367474
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,26427,135,1.37 [1.02-1.83],0.033501743340206
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Later onset COPD,26230,217,1.20 [0.95-1.52],0.1200014849056749
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27640,155,0.90 [0.67-1.21],0.4815402286652763
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Nasal polyp,26219,108,1.20 [0.86-1.67],0.289139510507142
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27442,605,1.18 [1.03-1.37],0.0194557737249467
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,27472,1225,1.21 [1.10-1.34],0.0001632518490916
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26997,886,1.09 [0.96-1.22],0.1753572825021537
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other pleural conditions,26281,34,1.53 [0.89-2.63],0.1227082303275612
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27594,195,1.26 [0.99-1.62],0.0643413606311194
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27566,840,1.28 [1.13-1.44],5.294649763051072e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,26825,578,1.21 [1.05-1.40],0.0094751339474894
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural plaque,26300,53,1.51 [0.97-2.35],0.069190996744241
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27263,988,1.14 [1.02-1.28],0.0206265100470118
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27621,136,0.89 [0.65-1.22],0.4704111131824469
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pneumothorax,26311,64,1.64 [1.11-2.43],0.0138381729291383
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pollen allergy,27613,265,1.06 [0.85-1.32],0.6139576734977218
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pulmonary oedema,27436,37,1.06 [0.58-1.92],0.8507176277356244
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20431,38,0.96 [0.53-1.75],0.9021700339080432
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27425,588,1.16 [1.00-1.34],0.043910532829096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26419,308,1.09 [0.89-1.33],0.4036879781236924
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Viral pneumonia,26460,185,1.22 [0.94-1.57],0.1348304550815079
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27388,159,1.02 [0.77-1.36],0.8693292300686609
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,15979,101,0.83 [0.57-1.21],0.3362467133440145
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21176,65,1.05 [0.67-1.63],0.8431286817642466
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute appendicitis,27449,160,0.79 [0.58-1.06],0.1134614517844534
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute gastritis,22109,74,0.88 [0.57-1.36],0.5615295456276805
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis,26062,158,1.16 [0.88-1.53],0.2998061581765967
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute peritonitis,27216,73,0.83 [0.54-1.29],0.4126371647048285
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26868,82,0.99 [0.66-1.47],0.9464687627201096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Barrett oesophagus,22381,346,0.98 [0.81-1.19],0.8293411411213965
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25958,54,1.03 [0.63-1.68],0.920638074585168
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27240,54,1.02 [0.62-1.66],0.95009213106749
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholecystitis,26081,177,1.10 [0.84-1.44],0.4717586331780233
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholelithiasis,26812,908,1.04 [0.93-1.18],0.4713202601124111
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic gastritis,22289,254,1.15 [0.92-1.43],0.219403819677225
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25947,43,0.91 [0.52-1.60],0.7346910768823772
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27502,77,1.01 [0.67-1.53],0.949411345375155
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Coeliac disease,26237,117,1.29 [0.95-1.77],0.1068979502628391
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Collagenous colitis,26082,57,1.08 [0.67-1.73],0.7622778263046572
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27465,208,1.00 [0.78-1.29],0.9846170708250676
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Constipation,27428,1171,1.14 [1.03-1.26],0.0128249293890246
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn disease,26121,96,1.00 [0.69-1.44],0.983575073895336
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27302,67,0.94 [0.60-1.46],0.7713506386565938
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26118,93,1.01 [0.70-1.47],0.9532762029463716
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Dental caries,26813,258,1.17 [0.95-1.45],0.1451412161374716
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25587,1828,1.04 [0.96-1.13],0.35912374051265
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of appendix,27490,201,0.97 [0.75-1.25],0.8115464539884263
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of liver,27531,745,1.09 [0.96-1.25],0.1718157446065942
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25931,3896,1.03 [0.97-1.09],0.3583790310252714
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27158,603,1.15 [1.00-1.33],0.052964836874903
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27566,423,1.04 [0.87-1.24],0.6699424599162632
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26681,126,1.22 [0.90-1.66],0.199772813520721
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26522,71,0.98 [0.64-1.50],0.9180459742524706
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27374,1254,1.10 [0.99-1.21],0.0663507782520778
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of tongue,26536,123,0.79 [0.56-1.11],0.1764235746460894
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27136,1232,1.04 [0.94-1.15],0.4260497213577744
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23550,2439,1.05 [0.98-1.13],0.1752728962021139
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Duodenal ulcer,22180,145,0.92 [0.68-1.24],0.5672868498689874
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27579,114,0.90 [0.64-1.26],0.5316200268057507
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27508,80,1.27 [0.87-1.86],0.2194315512979387
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26884,98,1.06 [0.74-1.52],0.7565124917316397
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21291,180,0.96 [0.73-1.26],0.761055091005536
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Functional dyspepsia,22553,518,0.94 [0.80-1.10],0.4435111534637268
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastric ulcer,22312,277,0.96 [0.77-1.20],0.7433346978796664
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24278,2243,1.08 [1.01-1.17],0.0336034787466864
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22439,404,0.95 [0.79-1.14],0.5844751578262173
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,22586,8076,1.04 [1.00-1.08],0.0862712649071654
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,GI-bleeding,27132,1012,1.09 [0.97-1.22],0.1303353520869152
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26615,60,1.54 [1.01-2.32],0.04236035666906
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22037,1290,1.09 [0.98-1.20],0.1025282982891046
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26841,55,1.40 [0.89-2.18],0.141087450016497
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Hernia,26494,2735,1.02 [0.95-1.09],0.5864611911469992
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impacted teeth,27517,74,1.35 [0.92-1.99],0.12593944034297
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impaction of intestines,21145,34,1.71 [1.00-2.94],0.0503312346086996
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Inguinal hernia,24429,670,1.00 [0.87-1.15],0.9869012370080196
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",23838,79,0.90 [0.59-1.35],0.6034512599258519
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21185,74,0.92 [0.60-1.41],0.6903869300446561
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26256,136,1.28 [0.95-1.71],0.1010354103097986
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21682,571,0.98 [0.84-1.14],0.7550769286593577
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27623,391,1.15 [0.96-1.37],0.1259409559764256
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26721,696,1.04 [0.91-1.20],0.5462830297052496
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26908,883,1.05 [0.93-1.19],0.387146100446391
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22187,152,1.32 [1.00-1.73],0.0487856532479073
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophagitis,22525,490,1.14 [0.97-1.33],0.11721494946198
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27604,132,1.39 [1.04-1.85],0.0256403806074547
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23804,45,1.31 [0.79-2.18],0.2921219408075501
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22409,1298,1.00 [0.91-1.11],0.9530490019064386
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26101,197,1.00 [0.77-1.29],0.977776203510073
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26066,162,1.14 [0.86-1.50],0.3536021625354643
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestine,22626,1515,0.94 [0.86-1.04],0.2361142522039556
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestines,26008,4897,1.02 [0.97-1.07],0.4888691059865095
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26526,194,1.27 [0.99-1.61],0.0581204641678656
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of liver,27389,603,1.10 [0.95-1.26],0.2135905887148206
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22568,533,1.04 [0.89-1.22],0.5852752546295905
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25984,80,0.96 [0.64-1.45],0.8508892974717539
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27509,366,1.07 [0.89-1.29],0.4550557360892002
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22808,773,0.99 [0.87-1.13],0.8789525541665398
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27144,1024,1.09 [0.98-1.22],0.1173939453381619
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26735,180,1.23 [0.95-1.59],0.109945081981797
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22324,1213,1.11 [1.00-1.23],0.0449927904062014
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23831,1796,1.03 [0.95-1.12],0.4853654467276372
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26865,79,0.95 [0.63-1.43],0.8131925854936273
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26796,771,1.04 [0.91-1.18],0.5465481814338526
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21340,229,1.24 [0.99-1.56],0.0615303862973863
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27493,94,1.33 [0.94-1.88],0.1078738858646639
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21457,346,1.09 [0.90-1.32],0.371368149315043
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26256,136,1.06 [0.78-1.44],0.7097182840356979
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27638,58,0.98 [0.60-1.58],0.919036226873361
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26571,124,1.08 [0.79-1.49],0.6266052601290626
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Toxic colitis,26057,32,1.06 [0.56-2.00],0.851402424165937
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22219,184,1.14 [0.88-1.48],0.3068864905830789
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcerative colitis,26169,144,1.18 [0.88-1.58],0.2659569585372028
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26151,126,1.14 [0.83-1.55],0.4222276636433499
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Umbilical hernia,24038,279,0.90 [0.72-1.12],0.3403276912573046
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21214,103,0.90 [0.62-1.30],0.5695738013518881
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ventral hernia,23981,222,0.99 [0.77-1.26],0.934152639081394
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Volvulus,21175,64,0.74 [0.46-1.20],0.2267285356895186
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27593,159,1.07 [0.81-1.41],0.6462630411643637
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27374,76,1.09 [0.73-1.64],0.6744537677643282
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26163,149,1.11 [0.83-1.48],0.499400859119384
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27021,545,1.05 [0.90-1.22],0.5347190171374698
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26673,197,1.15 [0.89-1.47],0.2841203442133269
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26185,171,1.27 [0.98-1.65],0.0762067578390733
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27385,226,1.38 [1.10-1.72],0.0049328932740843
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27550,391,1.28 [1.08-1.52],0.0048131808102222
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27206,47,1.23 [0.75-2.03],0.4134429390188274
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26180,2582,1.07 [1.00-1.15],0.0438208001741281
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27188,443,1.00 [0.85-1.19],0.9665107004891236
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27062,317,1.01 [0.82-1.23],0.9503408708874344
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27261,785,1.09 [0.96-1.24],0.1873882448346009
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27636,46,1.05 [0.62-1.78],0.8492983965840193
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26071,57,1.30 [0.82-2.04],0.2635054078637148
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26787,42,1.46 [0.88-2.42],0.1417641347010241
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27379,220,1.37 [1.09-1.72],0.0060803158037738
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26305,291,1.21 [0.99-1.47],0.0677249596834356
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26047,33,1.25 [0.69-2.26],0.4592090095847433
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27564,70,1.32 [0.88-1.98],0.1784375470781692
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26615,139,1.50 [1.14-1.98],0.0036095998131345
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27455,157,0.89 [0.66-1.20],0.4439640571745873
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27190,31,1.17 [0.63-2.18],0.6259862060418286
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26065,51,1.11 [0.68-1.82],0.668650212637862
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27121,1107,1.11 [1.00-1.24],0.0472582993251589
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26336,322,1.29 [1.07-1.56],0.0072691745117176
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26051,37,1.40 [0.81-2.41],0.2255687546882366
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27564,266,0.97 [0.77-1.21],0.7544378362137893
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27220,61,1.12 [0.71-1.76],0.6342888817696731
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27517,219,0.97 [0.76-1.24],0.8018961546028021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27616,182,1.07 [0.82-1.39],0.6287334425250204
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26139,125,1.22 [0.89-1.66],0.2125559251151685
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26207,193,0.89 [0.69-1.17],0.4085303874515915
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27607,173,1.03 [0.79-1.35],0.8074518307432079
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26144,130,1.13 [0.83-1.54],0.4345574528164426
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27614,120,1.18 [0.86-1.62],0.3013663620588157
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24275,134,1.36 [1.02-1.82],0.0363628294777542
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25824,4659,1.03 [0.97-1.08],0.3559635129888572
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24458,3293,1.05 [0.99-1.12],0.1116239435151414
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24236,95,0.99 [0.68-1.43],0.93786968990555
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24824,153,1.38 [1.05-1.81],0.0196821591858557
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24832,161,1.20 [0.91-1.58],0.1858051367203124
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27418,115,0.86 [0.61-1.21],0.3806229541577884
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",24717,46,1.07 [0.63-1.80],0.803255456131097
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21913,748,1.09 [0.96-1.24],0.1850437801417593
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27589,123,1.07 [0.77-1.48],0.6867076947816149
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24965,294,1.26 [1.03-1.54],0.0218454939477713
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24195,6249,1.04 [1.00-1.09],0.0663418166094941
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26286,109,0.93 [0.65-1.32],0.6767113983234201
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24253,112,0.89 [0.63-1.27],0.5279397585657556
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24753,612,1.23 [1.07-1.41],0.0042360399168822
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26765,2094,1.09 [1.01-1.18],0.0228540071757632
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24366,225,1.09 [0.86-1.38],0.4996566062961817
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24418,277,1.23 [1.00-1.52],0.0491068430260612
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24291,150,1.31 [0.99-1.73],0.0545858901373802
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27135,35,0.95 [0.51-1.77],0.8760512669550271
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22481,1316,1.03 [0.93-1.14],0.5570742604160078
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21560,395,1.13 [0.95-1.35],0.1614137399010864
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27596,385,1.15 [0.96-1.37],0.1209620358031205
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21233,68,1.21 [0.79-1.84],0.3875321505713267
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21517,352,0.89 [0.73-1.09],0.2586318203366398
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24471,330,1.11 [0.91-1.35],0.2923351352247002
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,21927,762,1.03 [0.90-1.17],0.6879525758066773
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,24699,28,0.76 [0.37-1.56],0.4511719067131989
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25228,557,1.13 [0.98-1.32],0.0975051112455878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24957,286,1.25 [1.02-1.53],0.03246686102383
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,21878,713,0.99 [0.86-1.13],0.8420340358695575
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24224,83,1.54 [1.07-2.20],0.0189810825636446
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24203,62,1.34 [0.87-2.06],0.1854776403751976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26230,53,1.31 [0.83-2.08],0.2446254455563563
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27314,1137,1.08 [0.97-1.20],0.1442053191698711
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26820,643,1.09 [0.95-1.25],0.2286864728501229
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27538,345,1.14 [0.94-1.38],0.1689487668848039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,22942,1777,1.07 [0.98-1.16],0.1315955700958686
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21246,81,1.37 [0.95-1.98],0.0969383618263021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24221,80,1.30 [0.89-1.90],0.1781025534560668
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21191,26,0.83 [0.40-1.73],0.6224392781271078
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21277,112,0.83 [0.58-1.18],0.2927190698505105
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26408,231,0.92 [0.72-1.17],0.4865841197045795
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,26415,238,1.20 [0.95-1.50],0.1199285280590381
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27606,86,1.22 [0.84-1.77],0.2973249200063752
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26234,1563,1.15 [1.05-1.25],0.0023820124554064
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24257,116,0.88 [0.62-1.24],0.4661421257947198
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21284,119,0.76 [0.53-1.07],0.1189632137028973
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25306,635,1.14 [0.99-1.30],0.0747243047856031
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23201,2036,1.02 [0.94-1.10],0.6959862218723363
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27156,56,0.87 [0.53-1.44],0.5976870229657324
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27622,73,1.20 [0.80-1.80],0.380539497991697
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24223,82,0.99 [0.66-1.50],0.9785047779242328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25236,1095,1.13 [1.02-1.26],0.0217371443886547
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24207,66,1.05 [0.67-1.64],0.8456802491651607
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22276,1111,1.02 [0.92-1.14],0.6664190927155328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26277,100,0.95 [0.66-1.36],0.7693569849886466
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24210,69,1.36 [0.91-2.05],0.1367495817092342
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24788,117,1.01 [0.73-1.41],0.9381890926050148
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24545,404,1.08 [0.91-1.29],0.3828363572104994
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27311,211,1.23 [0.97-1.57],0.0828451896036063
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25135,464,1.16 [0.99-1.37],0.067923210248323
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27547,326,1.17 [0.97-1.42],0.1078234291382639
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27630,38,0.86 [0.47-1.58],0.6324865793713903
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24346,205,1.15 [0.90-1.46],0.2730701805639222
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22199,592,1.12 [0.97-1.30],0.125947980138572
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24644,503,1.09 [0.93-1.28],0.2877008079702465
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24314,173,1.12 [0.86-1.47],0.4012286288687161
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21202,37,0.53 [0.28-1.02],0.0575138331830865
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,22926,1761,1.05 [0.96-1.14],0.2939667516583164
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21611,446,0.96 [0.81-1.14],0.6095661919874928
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27186,86,1.35 [0.94-1.94],0.1017236240407985
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27571,51,1.07 [0.65-1.77],0.782434113661748
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26040,29,1.10 [0.57-2.10],0.7773408886885399
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21239,74,1.18 [0.79-1.77],0.4151609596111623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,24763,92,1.36 [0.96-1.93],0.0855227312986543
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21514,349,1.13 [0.93-1.36],0.2134850234687039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24415,274,1.00 [0.80-1.24],0.99153301414315
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24883,212,1.31 [1.04-1.65],0.0239874337219837
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24782,111,1.34 [0.98-1.85],0.0707905119416682
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,23444,50,1.15 [0.70-1.89],0.5857023898995892
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27633,41,0.77 [0.42-1.38],0.3771934548687924
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24750,609,1.07 [0.93-1.24],0.3290345193343127
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27189,89,1.12 [0.77-1.63],0.5568667706962318
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26556,2415,1.11 [1.03-1.19],0.0051141505920056
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24250,109,0.95 [0.66-1.35],0.7593519274619493
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25036,365,1.17 [0.97-1.41],0.0930362275324705
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26253,185,1.02 [0.78-1.32],0.905371013921782
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24820,149,1.32 [1.00-1.74],0.0499062547457042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25735,1064,1.04 [0.93-1.16],0.5160382249492089
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25378,707,1.05 [0.92-1.20],0.4524735833687683
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24186,45,1.04 [0.60-1.78],0.896844753563448
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27242,142,1.15 [0.86-1.55],0.3502058847157356
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24299,158,1.23 [0.93-1.62],0.1503726142178783
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24198,57,0.78 [0.47-1.30],0.3469912781393232
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21203,38,0.94 [0.52-1.70],0.8317975641223919
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27082,846,1.29 [1.15-1.45],2.3265411146226387e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11234,76,0.90 [0.58-1.38],0.6271294811665862
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,14940,78,0.80 [0.52-1.23],0.3103769170653261
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27353,325,1.00 [0.82-1.23],0.9669150882665272
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27090,62,0.57 [0.35-0.95],0.0298456744587223
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26931,695,1.20 [1.05-1.36],0.0082066027456162
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27454,31,1.29 [0.70-2.36],0.4154943469556342
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27472,189,1.18 [0.92-1.52],0.192476668766686
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cystitis,25426,162,1.00 [0.75-1.33],0.979793973995421
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dialysis,26297,61,1.72 [1.15-2.56],0.0078446910373843
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11929,1149,1.10 [1.00-1.22],0.056370119969105
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15067,205,0.86 [0.66-1.12],0.2768204784860101
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Endometriosis,11297,139,0.91 [0.66-1.25],0.5620437627179766
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11544,386,0.81 [0.67-0.98],0.0345670220170447
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11580,422,0.95 [0.80-1.14],0.5933084764503377
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23323,4304,1.06 [1.00-1.12],0.0504072345577826
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27494,71,1.91 [1.35-2.70],0.0002603858859674
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydrocele,10866,86,1.09 [0.74-1.59],0.6629087657949962
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26148,224,1.16 [0.92-1.46],0.2167813894771268
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11540,760,1.14 [1.01-1.29],0.0380715280281094
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,14932,237,0.83 [0.65-1.06],0.1419496761561547
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10886,106,1.43 [1.04-1.95],0.0253385872607836
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Irregular menses,14936,125,0.66 [0.47-0.94],0.0221656972872122
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11454,296,0.92 [0.74-1.15],0.4808122061350776
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25328,64,0.89 [0.56-1.41],0.6074543786140871
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12578,1420,1.02 [0.93-1.13],0.6499153942956205
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,10829,49,0.84 [0.49-1.43],0.5141194355268053
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11260,102,1.42 [1.01-2.00],0.043891759287917
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27636,37,1.58 [0.93-2.69],0.0898036276884869
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27643,47,0.69 [0.39-1.21],0.1949220873964552
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26786,1522,1.09 [0.99-1.19],0.0688411610551063
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25738,474,1.16 [0.99-1.36],0.0664016596505279
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,14928,66,0.98 [0.62-1.54],0.9221461550807076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27598,315,1.26 [1.04-1.53],0.019733622633627
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,10936,156,1.02 [0.77-1.35],0.9010265849993344
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,10900,120,1.16 [0.85-1.59],0.3449851607452983
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,10856,76,0.92 [0.61-1.40],0.7041486959138293
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27611,53,1.23 [0.77-1.97],0.3894913136287009
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26366,1102,1.11 [1.00-1.24],0.0489472629842465
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14813,118,0.98 [0.70-1.38],0.9185914123353774
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11243,85,1.08 [0.73-1.60],0.7066469596411785
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11383,225,0.91 [0.71-1.16],0.4471932461846771
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11217,59,1.30 [0.82-2.06],0.2610661761409624
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11265,107,1.40 [1.00-1.96],0.0490297445656645
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26180,256,1.08 [0.87-1.35],0.4846951765644305
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27395,112,1.20 [0.87-1.67],0.2700120311968191
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11344,186,1.08 [0.83-1.41],0.5527370003805937
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11238,80,0.81 [0.53-1.24],0.3391757230185175
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11584,426,1.00 [0.84-1.20],0.980579490164423
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11227,69,1.02 [0.66-1.60],0.9169674290067228
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11542,384,1.11 [0.92-1.33],0.2864856102721101
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27472,49,1.21 [0.74-2.00],0.4512039817160106
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10889,109,1.42 [1.04-1.93],0.0257264156465072
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27442,1518,1.16 [1.06-1.27],0.0010326775296379
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26063,139,1.31 [0.98-1.75],0.0656514543400328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26314,78,0.74 [0.48-1.14],0.1710868139977949
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27099,71,1.38 [0.93-2.04],0.1084885853819826
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25437,173,1.02 [0.77-1.34],0.8936472266239035
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27417,389,0.97 [0.81-1.16],0.7276558787625014
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11259,101,1.38 [0.98-1.95],0.0627148393716863
